NASDAQ: BLCM       Bellicum Pharma Comm
Last Price Today's Change   Day's Range   Trading Volume
6.10   -0.40 (6.15%)  6.06 - 6.68  32,500


Avg Volume (4 weeks):42,404
4 Weeks Range:6.06 - 7.84
4 Weeks Price Volatility (%):
52 Weeks Range:0.721 - 12.15
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company. Its research areas are cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases. The company’s expertise is based on the inclusion of powerful molecular switches planned to eliminate, reduce, or activate therapeutic cells to increase efficacy and safety compared with existing cell therapies. Its pipeline portfolio includes adjunct T-cell therapy (BPX-501) to treat leukemias, lymphomas, and genetic blood diseases; CAR T cells technology (BPX-601) to treat prostate, pancreatic, bladder, esophagus, and gastric cancers; and T cell receptors (BPX-701) to treat blood cancers and solid tumors.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3796  4588  642  217 

Top 10 Active Counters
 CBLI 3.17+1.00 
 WEI 5.13+4.311 
 AAPL 117.51+1.53 
 HTZ 1.84-0.33 
 ACOR 0.962+0.272 
 NIO 27.96+0.33 
 GE 7.34+0.05 
 SQQQ 21.69-0.16 
 OAS 0.155-0.014 
 DKNG 42.53-2.05